文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于 CT 的临床Ⅰ期肺腺癌影像学基因组分析:与组织病理学特征和肿瘤学结局的关系。

CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes.

机构信息

From the Department of Radiology (R.P., J.A.A., P.G., M.S.G.), Druckenmiller Center for Lung Cancer Research (R.P., K.S.T., N.R., M.S.G., D.R.J.), Thoracic Surgery Service (J.G.C., R.C., J.Z., D.R.J.), Biostatistics Service, Department of Epidemiology and Biostatistics (K.W., K.S.T.), and Department of Pathology (N.R.), Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 7, New York, NY 10065.

出版信息

Radiology. 2022 Jun;303(3):664-672. doi: 10.1148/radiol.211582. Epub 2022 Mar 1.


DOI:10.1148/radiol.211582
PMID:35230187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9131171/
Abstract

Background A preoperative predictive model is needed that can be used to identify patients with lung adenocarcinoma (LUAD) who have a higher risk of recurrence or metastasis. Purpose To investigate associations between CT-based radiomic consensus clustering of stage I LUAD and clinical-pathologic features, genomic data, and patient outcomes. Materials and Methods Patients who underwent complete surgical resection for LUAD from April 2014 to December 2017 with preoperative CT and next-generation sequencing data were retrospectively identified. Comprehensive radiomic analysis was performed on preoperative CT images; tumors were classified as solid, ground glass, or mixed. Patients were clustered into groups based on their radiomics features using consensus clustering, and clusters were compared with tumor genomic alterations, histopathologic features, and recurrence-specific survival (Kruskal-Wallis test for continuous data, χ or Fisher exact test for categorical data, and log-rank test for recurrence-specific survival). Cluster analysis was performed on the entire cohort and on the solid, ground-glass, and mixed lesion subgroups. Results In total, 219 patients were included in the study (median age, 68 years; interquartile range, 63-74 years; 150 [68%] women). Four radiomic clusters were identified. Cluster 1 was associated with lepidic, acinar, and papillary subtypes (76 of 90 [84%]); clusters 2 (13 of 50 [26%]) and 4 (13 of 45 [29%]) were associated with solid and micropapillary subtypes ( < .001). The alterations were highest in cluster 1 (38 of 90 [42%], = .004). Clusters 2, 3, and 4 were associated with lymphovascular invasion (19 of 50 [38%], 14 of 34 [41%], and 28 of 45 [62%], respectively; < .001) and tumor spread through air spaces (32 of 50 [64%], 21 of 34 [62%], and 31 of 45 [69%], respectively; < .001). alterations (14 of 45 [31%]; = .006), phosphoinositide 3-kinase pathway alterations (22 of 45 [49%], < .001), and risk of recurrence (log-rank < .001) were highest in cluster 4. Conclusion CT-based radiomic consensus clustering enabled identification of associations between radiomic features and clinicalpathologic and genomic features and outcomes in patients with clinical stage I lung adenocarcinoma. © RSNA, 2022 See also the editorial by Nishino in this issue.

摘要

背景 需要一种术前预测模型,用于识别肺腺癌(LUAD)患者,这些患者具有更高的复发或转移风险。目的 探讨 CT 基于放射组学共识聚类的 I 期 LUAD 与临床病理特征、基因组数据和患者结局之间的关联。材料与方法 回顾性分析 2014 年 4 月至 2017 年 12 月期间因 LUAD 行完全手术切除且术前有 CT 和下一代测序数据的患者。对术前 CT 图像进行全面的放射组学分析;肿瘤分为实性、磨玻璃样或混合性。根据放射组学特征对患者进行共识聚类分组,并对聚类与肿瘤基因组改变、组织病理学特征和复发特异性生存进行比较(连续数据的 Kruskal-Wallis 检验、分类数据的 χ 检验或 Fisher 确切检验、以及复发特异性生存的对数秩检验)。对整个队列和实性、磨玻璃样和混合性病变亚组进行聚类分析。结果 共纳入 219 例患者(中位年龄,68 岁;四分位间距,63-74 岁;150 [68%] 例女性)。确定了 4 个放射组学聚类。聚类 1 与贴壁、腺泡和乳头亚型相关(76/90 [84%]);聚类 2(50/50 [26%])和聚类 4(45/45 [29%])与实性和微乳头亚型相关( <.001)。聚类 1 的 改变率最高(38/90 [42%], =.004)。聚类 2、3 和 4 与脉管侵犯(50/50 [64%]、34/34 [41%]和 45/45 [62%], <.001)和肿瘤通过气腔播散(50/50 [64%]、34/34 [62%]和 45/45 [69%], <.001)相关。聚类 4 的 改变率(14/45 [31%]; =.006)、磷酸肌醇 3-激酶通路改变率(22/45 [49%], <.001)和复发风险(对数秩 <.001)最高。结论 CT 基于放射组学的共识聚类可识别临床 I 期肺腺癌患者的放射组学特征与临床病理和基因组特征及结局之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9131171/4455abab7f73/radiol.211582.VA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9131171/4455abab7f73/radiol.211582.VA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9131171/4455abab7f73/radiol.211582.VA.jpg

相似文献

[1]
CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes.

Radiology. 2022-6

[2]
Diagnosis of Invasive Lung Adenocarcinoma Based on Chest CT Radiomic Features of Part-Solid Pulmonary Nodules: A Multicenter Study.

Radiology. 2020-8-25

[3]
A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.

Ther Adv Respir Dis. 2024

[4]
Histopathologic Basis for a Chest CT Deep Learning Survival Prediction Model in Patients with Lung Adenocarcinoma.

Radiology. 2022-11

[5]
Feasibility of UTE-MRI-based radiomics model for prediction of histopathologic subtype of lung adenocarcinoma: in comparison with CT-based radiomics model.

Eur Radiol. 2024-5

[6]
CT-based radiomic phenotypes of lung adenocarcinoma: a preliminary comparative analysis with targeted next-generation sequencing.

Front Med (Lausanne). 2023-8-17

[7]
Prediction of solid and micropapillary components in lung invasive adenocarcinoma: radiomics analysis from high-spatial-resolution CT data with 1024 matrix.

Jpn J Radiol. 2024-6

[8]
Consensus Clustering Analysis Based on Enhanced-CT Radiomic Features: Esophageal Squamous Cell Carcinoma patients' 3-Year Progression-Free Survival.

Acad Radiol. 2024-7

[9]
A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.

Phys Med Biol. 2020-3-6

[10]
Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas.

Thorac Cancer. 2020-4

引用本文的文献

[1]
Consensus clustering based on CT radiomics has potential for risk stratification of patients with clinical T1 stage lung adenocarcinoma.

BMC Med Imaging. 2025-7-1

[2]
Progress and challenges of artificial intelligence in lung cancer clinical translation.

NPJ Precis Oncol. 2025-7-1

[3]
Interpretable machine learning model integrating contrast-enhanced CT environmental radiomics and clinicopathological features for predicting postoperative recurrence in lung adenocarcinoma: a retrospective pilot study.

Front Oncol. 2025-5-23

[4]
Image-Based Deep Learning Model for Predicting Lymph Node Metastasis in Lung Adenocarcinoma With CT ≤ 2 cm.

Thorac Cancer. 2025-5

[5]
A comprehensive analysis identified an autophagy-related risk model for predicting recurrence and immunotherapy response in stage I lung adenocarcinoma.

PeerJ. 2025-5-2

[6]
Unsupervised machine learning analysis of optical coherence tomography radiomics features for predicting treatment outcomes in diabetic macular edema.

Sci Rep. 2025-4-18

[7]
Nomogram based on computed tomography radiomics features and clinicopathological factors to predict the prognosis of patients with non-small cell lung cancer receiving immune checkpoint inhibitor rechallenge.

Transl Lung Cancer Res. 2025-3-31

[8]
Development and validation of CT radiomics diagnostic models: differentiating benign from malignant pulmonary nodules and evaluating malignancy degree.

J Thorac Dis. 2025-3-31

[9]
Cardiovascular magnetic resonance radiologic-pathologic correlation in radiomic analysis of myocardium in non-ischemic dilated cardiomyopathy.

J Cardiovasc Magn Reson. 2025

[10]
Spectral dual-layer detector CT-based radiomics-deep learning for predicting pathological aggressiveness of stage I lung adenocarcinoma: discrimination of precursor glandular lesions and invasive adenocarcinomas.

Transl Lung Cancer Res. 2025-2-28

本文引用的文献

[1]
Sotorasib for Lung Cancers with p.G12C Mutation.

N Engl J Med. 2021-6-24

[2]
Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung Adenocarcinoma.

Clin Cancer Res. 2021-5-1

[3]
Prediction of micropapillary and solid pattern in lung adenocarcinoma using radiomic values extracted from near-pure histopathological subtypes.

Eur Radiol. 2021-7

[4]
A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.

JAMA Surg. 2021-2-1

[5]
KRAS Inhibition with Sotorasib in Advanced Solid Tumors.

N Engl J Med. 2020-9-20

[6]
The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.

J Thorac Oncol. 2020-12

[7]
CT-Imaging Based Analysis of Invasive Lung Adenocarcinoma Presenting as Ground Glass Nodules Using Peri- and Intra-nodular Radiomic Features.

Front Oncol. 2020-5-27

[8]
Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics.

Clin Cancer Res. 2020-5-1

[9]
Application of Radiomics in Predicting the Malignancy of Pulmonary Nodules in Different Sizes.

AJR Am J Roentgenol. 2019-9-26

[10]
Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma.

Clin Cancer Res. 2019-8-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索